Ad is loading...
BRSYF
Price
$3.15
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
WUXIF
Price
$3.78
Change
-$0.00 (-0.00%)
Updated
Sep 10 closing price
Ad is loading...

BRSYF vs WUXIF

Header iconBRSYF vs WUXIF Comparison
Open Charts BRSYF vs WUXIFBanner chart's image
Brainsway
Price$3.15
Change-$0.00 (-0.00%)
Volume$500
CapitalizationN/A
Wuxi Apptec
Price$3.78
Change-$0.00 (-0.00%)
Volume$2.22K
CapitalizationN/A
BRSYF vs WUXIF Comparison Chart
Loading...
View a ticker or compare two or three
VS
BRSYF vs. WUXIF commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRSYF is a Hold and WUXIF is a Hold.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (BRSYF: $3.15 vs. WUXIF: $3.78)
Brand notoriety: BRSYF and WUXIF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BRSYF: 80% vs. WUXIF: 100%
Market capitalization -- BRSYF: $39.9M vs. WUXIF: $31.13B
BRSYF [@Medical Specialties] is valued at $39.9M. WUXIF’s [@Medical Specialties] market capitalization is $31.13B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRSYF’s FA Score shows that 0 FA rating(s) are green whileWUXIF’s FA Score has 1 green FA rating(s).

  • BRSYF’s FA Score: 0 green, 5 red.
  • WUXIF’s FA Score: 1 green, 4 red.
According to our system of comparison, WUXIF is a better buy in the long-term than BRSYF.

Price Growth

BRSYF (@Medical Specialties) experienced а 0.00% price change this week, while WUXIF (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.

Industries' Descriptions

@Medical Specialties (-4.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

FUNDAMENTALS
Fundamentals
WUXIF($31.1B) has a higher market cap than BRSYF($39.9M). BRSYF YTD gains are higher at: 65.789 vs. WUXIF (-61.934). WUXIF has higher annual earnings (EBITDA): 11.4B vs. BRSYF (-13.7M). WUXIF has more cash in the bank: 9.95B vs. BRSYF (44.3M). BRSYF has less debt than WUXIF: BRSYF (754K) vs WUXIF (5.73B). WUXIF has higher revenues than BRSYF: WUXIF (39.8B) vs BRSYF (25.8M).
BRSYFWUXIFBRSYF / WUXIF
Capitalization39.9M31.1B0%
EBITDA-13.7M11.4B-0%
Gain YTD65.789-61.934-106%
P/E RatioN/A19.57-
Revenue25.8M39.8B0%
Total Cash44.3M9.95B0%
Total Debt754K5.73B0%
FUNDAMENTALS RATINGS
BRSYF: Fundamental Ratings
BRSYF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
86
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
EOS.X0.6727470.090494
+15.54%
EOS cryptocurrency
BULL.X0.0847100.005664
+7.17%
Tron Bull cryptocurrency
ONE.X0.0149540.000999
+7.16%
Harmony cryptocurrency
VIDT.X0.0337320.001629
+5.07%
VIDT DAO cryptocurrency
PVI24.81-0.08
-0.31%
Invesco Floating Rate MunicipalIncomeETF

BRSYF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRSYF has been loosely correlated with ANSLY. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if BRSYF jumps, then ANSLY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRSYF
1D Price
Change %
BRSYF100%
N/A
ANSLY - BRSYF
61%
Loosely correlated
N/A
IOBCF - BRSYF
39%
Loosely correlated
N/A
VERO - BRSYF
30%
Poorly correlated
-12.61%
WUXIF - BRSYF
27%
Poorly correlated
N/A
PDEX - BRSYF
23%
Poorly correlated
-3.56%
More

WUXIF and

Correlation & Price change

A.I.dvisor tells us that WUXIF and BRSYF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that WUXIF and BRSYF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WUXIF
1D Price
Change %
WUXIF100%
N/A
BRSYF - WUXIF
27%
Poorly correlated
N/A
FDMDF - WUXIF
23%
Poorly correlated
N/A
ADMT - WUXIF
22%
Poorly correlated
-12.39%
USAQ - WUXIF
13%
Poorly correlated
N/A
ZTEK - WUXIF
7%
Poorly correlated
+29.96%
More